Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. injectable implant
Show results for
Products
Services
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Injectable Implant Articles & Analysis

13 news found

CD Formulation Introduces Comprehensive Range of Microsphere and Microneedle Solutions for Pharma and Biotech Applications

CD Formulation Introduces Comprehensive Range of Microsphere and Microneedle Solutions for Pharma and Biotech Applications

Microspheres are tiny spherical particles containing drugs that can be injected or implanted for sustained release, allowing a slow and controlled delivery of the therapeutic agent to the targeted site. ...

ByCD Formulation


CD Formulation Newly Launches 100+ Raw Materials for Preparation of Microspheres and Microneedles

CD Formulation Newly Launches 100+ Raw Materials for Preparation of Microspheres and Microneedles

Polymer Microspheres The polymer microspheres range in diameter from 1 to 200 microns and can be loaded with different drugs or bioactive molecules depending on the application. The microspheres can be injected or implanted into the target tissue or organ, allowing the drug to be released locally with minimal systemic effects. ...

ByCD Formulation


Sight Sciences Announces First Patient Treated in TRIDENT European Trial to Evaluate the OMNI® Surgical System in Pseudophakic Eyes with Open-Angle Glaucoma

Sight Sciences Announces First Patient Treated in TRIDENT European Trial to Evaluate the OMNI® Surgical System in Pseudophakic Eyes with Open-Angle Glaucoma

(Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announced that the first patient has been treated in the novel TRIDENT clinical trial, designed to demonstrate the OMNI Surgical System with higher volume as a safe and effective standalone treatment option, compared to ...

BySight Sciences, Inc.


CD Formulation: Customized Preparation of Active Pharmaceutical Ingredient Excipients to Accelerate Drug Discovery Projects

CD Formulation: Customized Preparation of Active Pharmaceutical Ingredient Excipients to Accelerate Drug Discovery Projects

All pharmaceutical excipients provided by CD Formulation can be used in various medical products such as capsules, tablets, oral liquids, inhalers, implants and injections. Please visit https://www.formulationbio.com/products/active-pharmaceutical-ingredient-excipients.html to learn more. ...

ByCD Formulation


FDA Clears Jointechlabs’ MiniTC for Point-of-Care Fat Tissue Processing and its Broad Range of Applications

FDA Clears Jointechlabs’ MiniTC for Point-of-Care Fat Tissue Processing and its Broad Range of Applications

The final product of the processing is a fine washed fractured fat tissue known as fat graft or microfat. When implanted by injection, the essential effect can be attributed to the preservation of the integrity of fat tissue and the stromal cells within its natural niche. ...

ByJointechlabs Inc.


First U.S. Patient Treated in OASIS Clinical Trial of RENOVA iStim System for Overactive Bladder

First U.S. Patient Treated in OASIS Clinical Trial of RENOVA iStim System for Overactive Bladder

“I’m pleased to say that our first implant procedure went smoothly. The RENOVA iStim implant was placed during an outpatient procedure and treatment will now be done at the patient’s home. ...

ByBlueWind Medical


BlueWind Initiates U.S. Enrollment in Clinical Trial of the RENOVA iStim to Treat Overactive Bladder

BlueWind Initiates U.S. Enrollment in Clinical Trial of the RENOVA iStim to Treat Overactive Bladder

RENOVA is a tiny, battery-less and lead-less neurostimulation implant that provides a patient-centric, home-based alternative therapy option for women with OAB. ...

ByBlueWind Medical


KiOmed Pharma obtains CE mark and signs a License and Supply Agreement

KiOmed Pharma obtains CE mark and signs a License and Supply Agreement

KiOmed Pharma announces the granting of the CE mark for its first implantable product intended to treat osteoarthritis symptoms and the signing of a License and Supply Agreement with TRB Chemedica, a leading pharmaceutical and biotechnology company. KiOmed Pharma announces the granting of the CE mark for its first implantable product intended to treat osteoarthritis symptoms and the signing of a ...

ByKiOmed Pharma


Implantable Sensors Offer Data-Driven Telemedicine for Vulnerable Populations in an Era of Covid19

Implantable Sensors Offer Data-Driven Telemedicine for Vulnerable Populations in an Era of Covid19

Sensor-enabled digital health solutions: how they work By periodically uploading continuous data to the cloud, implantable sensors offer a reimbursable, data-driven solution that may improve outcomes, providing an unprecedented window on fluctuation of chronic disease indicators and risk factors. ...

ByInjectsense, Inc.


BlueWind Medical Appoints Dan Lemaitre as Chief Executive Officer

BlueWind Medical Appoints Dan Lemaitre as Chief Executive Officer

"Our RENOVA device, is easy to implant, potentially devoid of severe complications and is in a form factor that works for physicians and patients alike. ...

ByBlueWind Medical


DiscGenics Announces Publication of Preclinical Data for Disc Degeneration Treatment in The Spine Journal

DiscGenics Announces Publication of Preclinical Data for Disc Degeneration Treatment in The Spine Journal

IDCT is a homologous, allogeneic, injectable disc cell therapy that utilizes Discogenic Cells to offer a non-surgical, potentially regenerative solution for the treatment of patients with mild to moderate DDD. ...

ByDiscGenics, Inc.


Microneedle patch technology shows potential for long-acting contraception

Microneedle patch technology shows potential for long-acting contraception

The technology, licensed exclusively by Micron Biomedical, shows the potential to offer an attractive alternative to current long-acting contraceptive options, which can be costly and require an injection or the implantation of a device by a healthcare professional. ...

ByMicron Biomedical, Inc.


Summary of IARC Working Group Meeting on Some Nanomaterials and Some Fibers Published

Summary of IARC Working Group Meeting on Some Nanomaterials and Some Fibers Published

Sufficient evidence of carcinogenicity was also reported in experimental animals, with increased incidences of mesotheliomas observed in one study in male and female rats given fibrous fluoro-edenite by intraperitoneal or intrapleural injection. The results of the few available mechanistic studies were consistent with proposed mechanisms of fibre carcinogenicity. ...

ByBergeson & Campbell, P.C.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT